Activation of PP2A-like phosphatase and modulation of tau phosphorylation accompany stress-induced apoptosis in cultured oligodendrocytes

GLIA

Volumn 40, Issue 3, 2002, Pages 271-282

  Goldbaum, Olaf ^a   Richter Landsberg, Christiane ^a  

^a UNIVERSITY OF OLDENBURG   (Germany)

Author keywords

Cytoskeleton; GSK 3 ; Heat shock; Myelin forming cells; Okadaic acid; Oxidative stress

Indexed keywords

ENZYME INHIBITOR; GLYCOGEN SYNTHASE KINASE 3; GLYCOGEN SYNTHASE KINASE 3 BETA; HYDROGEN PEROXIDE; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE 3; PHOSPHOPROTEIN PHOSPHATASE; TAU PROTEIN;

ANIMAL; APOPTOSIS; ARTICLE; CELL CULTURE; CELL INCLUSION; DEGENERATIVE DISEASE; DRUG ANTAGONISM; DRUG EFFECT; ENZYMOLOGY; HEAT SHOCK RESPONSE; METABOLISM; NEWBORN; OLIGODENDROGLIA; OXIDATIVE STRESS; PATHOPHYSIOLOGY; PHOSPHORYLATION; PHYSIOLOGY; PROTEIN PROCESSING; RAT; STRESS; WISTAR RAT;

ANIMALS; ANIMALS, NEWBORN; APOPTOSIS; CELLS, CULTURED; ENZYME INHIBITORS; GLYCOGEN SYNTHASE KINASE 3; HEAT-SHOCK RESPONSE; HYDROGEN PEROXIDE; INCLUSION BODIES; MITOGEN-ACTIVATED PROTEIN KINASE 3; MITOGEN-ACTIVATED PROTEIN KINASES; NEURODEGENERATIVE DISEASES; OLIGODENDROGLIA; OXIDATIVE STRESS; PHOSPHOPROTEIN PHOSPHATASE; PHOSPHORYLATION; PROTEIN PROCESSING, POST-TRANSLATIONAL; RATS; RATS, WISTAR; STRESS; TAU PROTEINS;

EID: 0036918128     PISSN: 08941491     EISSN: None     Source Type: Journal    
DOI: 10.1002/glia.10119     Document Type: Article

References (47)

1. Alessi DR, Cuenda A, Cohen P, Dudley DT, Saltierl AR. 1995. PD098059 is a specific inhibitor of the activation of mitogen-activated protein kinase kinase in vitro and in vivo. J Biol Chem 270:27489-27494.
2. Alvarez G, Munoz-Montano JR, Satrustegui J, Avila J, Bogonez E, Diaz-Nido J. 1999. Lithium protects cultured neurons against β-amyloid-induced neurodegeneration. FEBS Lett 453:260-264.
3. Bennecib M, Gong CX, Grundke-Iqbal I, Iqbal K. 2000. Role of protein phosphatase-2A and -1 in the regulation of GSK-3, cdk5 and cdc2 and the phosphorylation of tau in rat forebrain. FEBS Lett 485:87-93.
4. Berry RW, Quinn B, Johnson N, Binder LI. 2001. Pathological tau accumulations in neurodegenerative disease: Review and case report. Neurochem Int 39:469-479.
5. Billingsley ML, Kincaid RL. 1997. Regulated phosphorylation and dephosphorylation of tau protein: Effects on microtubule interaction, intracellular trafficking and neurodegeneration. Biochem J 323:577-591.
6. Buée L, Bussière T, Buée-Scherrer V, Delacourte A, Hof PR. 2000. Tau protein isoforms, phosphorylation and role in neurodegenerative disorders. Brain Res Rev 33:95-130.
7. Cairns NJ, Atkinson PF, Hanger DP, Anderton BH, Daniel SE, Lantos P. 1997 Tau protein in glial cytoplasmic inclusions of multiple system atrophy can be distinguished from abnormal tau in Alzheimer's disease. Neurosci Lett 230:49-52.
8. Chin SS-M, Goldman JE, 1996. Glial inclusions in CNS degenerative diseases, J Neuropathol Exp Neurol 55:499-508.
9. Cross DAE, Culbert AA, Chalmers KA, Facci L, Skaper SD, Reith AD. 2001. Selective small-molecule inhibitors of glycogen synthase kinase-3 activity protect primary neurones from death. J Neurochem 77:94-102.
10. Davis DR, Brion JP, Couck AM, Gallo JM, Hanger DP, Ladhan K, Lewis C, Miller CCJ, Rupniak T, Smith C, Anderton B. 1995. The phosphorylation state of the microtubule-associated protein tau as affected by glutamate, colchicine and β-amyloid in primary rat cortical neuronal cultures. Biochem J 309:941-949.
11. Favre B, Turowski P, Hemmings BA. 1997. Differential inhibition and posttranslational modification of protein phosphatase 1 and 2A in MCF7 cells treated with calyculin-A, okadaic acid, and tautomycin. J Biol Chem 272:13856-13863.
12. Ferrer I, Blanco R, Carmona M, Ribera R, Goutan E, Pulg B, Rey MJ, Cardozo A, Vinas F, Ribalta T. 2001. Phosphorylated Map kinase (erk1, erk2) expression is associated with early tau deposition in neurones and glial cells, but not with increased DNA vulnerability and cell death, in Alzheimer disease, Pick's disease, progressive supranuclear palsy and corticobasal degeneration. Brain Pathol 11:144-158.
13. Flaherty DB, Soria JP, Tomasiewicz, Wood JG. 2000. Phosphorylation of human tau protein by microtubule-associated kinases: GSK3β and cdk5 are key participants. J Neurosci Res 62:463-472.
14. Frame S, Cohen P. 2001. GSK3 takes centre stage more than 20 years after its discovery. Biochem J 359:1-16.
15. Goedert M, Spillantini MG, Davies SW. 1998. Filamentous nerve cell inclusions in neurodegenerative diseases. Curr Opin Neurobiol 8:619-632.
16. Goldbaum O, Richter-Landsberg C. 2001. Stress proteins in oligodendrocytes: Differential effects of heat shock and oxidative stress. J Neurochem 78:1233-1242.
17. Gong CX, Lidsky T, Wegiel J, Zuck L, Grundke-Iqbal I, Iqbal K. 2000. Phosphorylation of microtubule-associated protein tau is regulated by protein phosphatase 2A in the mammalian brain. J Biol Chem 275:5535-5544.
18. Gorath M, Stahnke T, Mronga T, Goldbaum O, Richter-Landsberg C. 2001. Developmental changes of tau protein and mRNA in cultured rat brain oligodendrocytes. Glia 36:89-101.
19. Head MW, Goldman JE. 2000. Small heat shock proteins, the cytoskeleton and inclusion body formation. Neuropathol Appl Neurobiol 26:304-312.
20. Hoeflich KP, Luo J, Ruble EA, Tsao MS, Jin O, Woodgett JR. 2000. Requirement for glycogen synthase kinase-3β and NF-κB activation. Nature 406:86-90.
21. Hong M, Chen DCR, Klein PS, Lee VMY. 1997. Lithium reduces tau phosphorylation by inhibition of glycogen synthase-3. J Biol Chem 272:25326-25332.
22. Hong M, Trojanowski JQ, Lee VMY. 2000. Tau-based neurofibrillary lesions. In: Clark CM, Trojanowski JQ, editors. Neurodegenerative Dementias. New York: McGraw-Hill. p 161-175.
23. Johnson GVW, Hartigan JA. 1998. Tau protein in normal and Alzheimer's disease brain: An update. Alzheimers Dis Rev 3:125-141.
24. Ko LW, Odawara T, Yen SHC. 1997. Menadione-induced tau dephosphorylation in cultured human neuroblastoma cells. Brain Res 760:118-128.
25. Krishnamurthy PK, Mays JL, Bijur GN, Johnson GVW. 2000. Transient oxidative stress in SH-SY5Y human neuroblastoma cells results in caspase dependent and independent cell death and tau proteolysis. J Neurosci Res 61: 515-523.
26. Leclerc S, Garnier M, Hoessel R, Markos D, Bibb JA, Snyder G, Greengard P, Biernat J, Wu YZ, Mandelkow EM, Eisenbrand G, Meijer L. 2001. Indirubins inhibit glycogen synthase kinase-3β and cdk5/p25, two protein kinases involved in abnormal tau phosphorylation in Alzheimer's disease. J Biol Chem 276:251-260.
27. Lee VMY, Goedert M, Trojanowski JQ. 2001. Neurodegenerative tauopathies. Annu Rev Neurosci 24:1121-1159.
28. LoPresti P, Konat GW. 2001. Hydrogen peroxide induces transient dephosphorylation of tau protein in cultured rat oligodendrocytes. Neurosci Lett 311:142-144.
29. McMorris FA, Miller SL, Pleasure D, Abramsky O. 1981. Expression of biochemical properties of oligodendrocytes in oligodendrocyte x glioma cell hybrids proliferating in vitro. Exp Cell Res 133:395-404.
30. Merrick SE, Trojanowski JQ, Lee VMY. 1997. Selective destruction of stable microtubules and axons by inhibitors of protein serine/threonine phosphatases in cultured human neurons. J Neurosci 17:5726-5737.
31. Mills JC, Lee VMY, Pittman RN. 1998. Activation of PP2A-like phosphatase and dephosphorylation of tau protein characterize onset of the execution phase of apoptosis. J Cell Sci 111:625-636.
32. Nakamura S, Kawamoto Y, Nakano S, Akiguchi I, Kimura J. 1998. Cyclin-dependent kinase-5 and mitogen-activated protein kinase in glial cytoplasmic inclusions in multiple system atrophy. J Neuropathol Exp Neurol 57:690-698.
33. Neuhoff V, Philipp K, Zimmer HG, Mesecke S. 1979. A simple, versatile, sensitive and volume-independent method for quantitative protein determination which is independent of other external influences. Hoppe-Seylers Z Physiol Chem 360:1657-1670.
34. Probst-Cousin S, Rickert CH, Schmid KW, Gulotta F. 1998. Cell death mechanisms in multiple system atrophy. J Neuropathol Exp Neurol 57:814-821.
35. Richter-Landsberg C. 2001. Organization and functional roles of the cytoskeleton in oligodendrocytes. Microsc Res Tech 53:628-636.
36. Richter-Landsberg C, Gorath M. 1999. Developmental regulation of alternatively spliced isoforms of mRNA encoding MAP2 and tau in rat brain oligodendrocytes during culture maturation. J Neurosci Res 56:259-270.
37. Richter-Landsberg C, Vollgraf U. 1998. Mode of cell injury and death after hydrogen peroxide exposure in cultured oligodendroglia cells. Exp Cell Res 244:218-229.
38. Schneider A, Biernat J, Von Bergen M, Mandelkow E, Mandelkow EM. 1999. Phosphorylation that detaches tau protein from microtubules (Ser261/Ser214) also protects it against aggregation into Alzheimer paired helical filaments. Biochemistry 38:3549-3558.
39. Shanavas A, Papasozomenos SC. 2000. Tau kinases in rat heat shock model: Possible implications for Alzheimer disease. Proc Natl Acad Sci U S A 97:14139-14144.
40. Smith KJ, Kapoor R, Felts PA. 1999. Demyelination: The role of oxygen and nitrogen species. Brain Pathol 9:69-92.
41. Sontag E, Nunbhakdi-Craig V, Lee G, Brandt R, Kamibayashi C, Kuret J, White CL, Mumby MC, Bloom GS. 1999. Molecular interactions among protein phosphatase 2A, tau and microtubules. J Biol Chem 274:25490-25498.
42. Spittaels K, Van den Haute C, Van Dorpe J, Geerts H, Mercken M, Bruynseels K, Lasrado R, Vandezande K, Laenen I, Boon T, Van Lint J, Vandenheede J, Moechars D, Loos R, Van Leuven F. 2000. Glycogen synthase kinase-3β phosphorylates protein tau and rescues the axonopathy in the central nervous system of human four-repeat tau transgenic mice. J Biol Chem 275:41340-41349.
43. Stoothoff WH, Johnson GVW. 1999. Hyperosmotic stress-induced apoptosis and tau phosphorylation in human neuoblastoma cells. J Neurosci Res 65:573-582.
44. Towbin HTM, Staehelin TM, Gordon J. 1979. Electrophoretic transfer of proteins from polyacryamide gels to nitrocellulose sheets: Procedure and some applications. Proc Natl Acad Sci U S A 76:4350-4354.
45. Vogelsberg-Ragaglia V, Bruce J, Richter-Landsberg C, Zhang B, Hong M, Trojanowski J, Lee VMY. 2000. Distinct FTDP-17 missense mutations in tau produce tau aggregates and other pathological phenotypes in transfected CHO cells. Mol Biol Cell 11:4093-4104.
46. Vollgraf U, Wegner M, Richter-Landsberg C. 1999. Activation of AP-1 and NF-kappaB transcription factors is involved in hydrogen peroxide-induced apoptotic cell death of oligodendrocytes. J Neurochem 73:2501-2509.
47. Zhang J, Johnson GVW. 2000. Tau protein is hyperphosphorylated in a site-specific manner in apoptotic neuronal PC12 cells. J Neurochem 75:2346-2357.